We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 2

<b>Figure 2</b>

Figure 2. From: Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial.

 Grade of endoscopic lesions (G0–4) at follow up (six months or earlier in case of clinical relapse) in patients receiving Lactobacillus johnsonii LA1 or placebo after surgery for Crohn's disease.

P Marteau, et al. Gut. 2006 June;55(6):842-847.

Supplemental Content

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
Write to the Help Desk